Effects of Glucose Fluctuation Intervention on the Prognosis of Patients With Type 2 Diabetes and Cerebral Infarction
Sponsor: Nanjing University of Traditional Chinese Medicine
Listed as NCT03932084, this NA trial focuses on Type 2 Diabetes and Cerebral Infarction and remains ongoing. Sponsored by Nanjing University of Traditional Chinese Medicine, it has been updated 5 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
May 2019 — Jan 2021 [monthly]
Recruiting NA
First recorded
Feb 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nanjing University of Traditional Chinese Medicine
For direct contact, visit the study record on ClinicalTrials.gov .